Research.Patient.info
metastatic pancreatic cancer research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- Other
Dose Escalation Phase 1 Study of IOA-289 in combination with gemcitabine/nab-paclitaxel
This study is testing a new medicine called IOA-289, given alongside standard chemotherapy (gemcitabine and nab-paclitaxel), for people with pancreatic cancer that has spread. It's an early-stage study to find the safest and most effective dose of IOA-289.
Italy - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase IIb, Open-label, Randomized Study of Nab-Paclitaxel and Gemcitabine plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer (VIRAGE)
This study is looking into a new treatment, VCN-01, alongside standard chemotherapy for pancreatic cancer that has spread. It aims to see how well patients live and if the new treatment is safe and tolerable.
Spain